SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments “Using our chemical synthesis platform we are able to directly synthesize Twist Multiplexed Gene Fragments as ...

The field of droplet microfluidics has emerged as a transformative approach for utilising microscale droplets as individual reaction compartments. This technology facilitates the precise manipulation ...

Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

This article is based on a poster originally authored by Ariane Jonetz-Mentzel et al. In biopharmaceutical laboratories, there is an increasing demand for label-free, high-throughput screening based ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

The global High Throughput Screening Market was valued at USD 13370 Million in the year 2024 and is projected to reach a revised size of USD 17880 Million by 2031, growing at a CAGR of 4.3% during the ...

Conventional high throughput screening for clinical candidates cannot evaluate over 99% of commercially available molecules, thereby restricting the accessible chemical search space for therapeutic ...

A research team from the University of Hong Kong has developed a general computational protocol for phosphorescent platinum(II) complexes via high throughput virtual screening and Δ-learning ...

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will discuss the ...